← Back to Search

Other

Neurorehabilitation of the Hand for Hand Function

N/A

Recruiting

Led By Aimee Nelson, PhD

Research Sponsored by IRegained Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline- before beginning the treatment and post treatment- after the conclusion of 15 treatment sessions, within 5 days

Awards & highlights

Study Summary

This trial will recruit 10 people with upper-limb impairments to use a device called IRegained for 15 days. Data will be collected before and after the trial to assess its effectiveness.

Eligible Conditions

Hand Function
Stroke

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline- before beginning the treatment and post treatment- after the conclusion of 15 treatment sessions, within 5 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline- before beginning the treatment and post treatment- after the conclusion of 15 treatment sessions, within 5 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline- before beginning the treatment and post treatment- after the conclusion of 15 treatment sessions, within 5 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

ABILHAND- Change is being assessed

Box and Block (BBT)- Change is being assessed

Chedoke Arm and Hand Activity Inventory 9 (CAHAI-9)- Change is being assessed

Secondary outcome measures

Finger Goniometry- Change is being assessed

Grip Dynamometry- Change is being assessed

Pinch Dynamometry- Change is being assessed

Trial Design

1Treatment groups

Experimental Treatment

Group I: Neurorehabilitation of the HandExperimental Treatment1 Intervention

Participants will undergo a 1-hour training session 5 days per week, over 3 weeks for a total of 15 sessions. Hand function therapy will be administered using the gamified protocol to enhance rehabilitation of the hand and provide participants with greater opportunity to regain hand function over the course of the study.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Treatment using the MyHand System

2022

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

McMaster UniversityOTHER

880 Previous Clinical Trials

2,597,818 Total Patients Enrolled

BaycrestOTHER

43 Previous Clinical Trials

5,957 Total Patients Enrolled

IRegained Inc.Lead Sponsor

3 Previous Clinical Trials

31 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this investigation extend to individuals aged 80 or older?

"For inclusion in this trial, patients must be at least 18 years of age and not older than 100."

Answered by AI

What is the present size of the patient pool participating in this clinical trial?

"Affirmative. Data hosted on clinicaltrials.gov indicates that this research, which was initially posted on October 19th 2022, is actively recruiting participants. 10 patients are needed to be recruited from a single medical centre."

Answered by AI

Are there any remaining slots for enrollment in this experiment?

"The clinical trial, which was first posted on October 19th 2022 and most recently edited on March 31st 2023, is still recruiting participants according to the information provided by clinicaltrials.gov."

Answered by AI

Is it feasible for me to participate in this medical study?

"To partake in this medical trial, stroke patients of between 18 and 100 years should apply. This clinical study is currently looking for 10 volunteers to take part."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Hand Training & Brain Changes

2022. "Hand Training & Brain Changes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05811819.